Who Owns Tvardi Therapeutics Stock?
NASDAQ: TVRDHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.05 -2.78%
Ownership breakdown
- Held by institutions
- 17.33%
- Held by insiders
- 24.36%
- Institutional holders
- 78
- Institutions 17.3%
- Insiders 24.4%
- Public and other 58.3%
Who owns Tvardi Therapeutics stock?
Institutional investors own about 17.3% of Tvardi Therapeutics's shares, spread across 78 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 24.36% of TVRD.
The largest institutional holders are Slate Path Capital, LP (5.28%), Vanguard Capital Management LLC (2.58%) and American Financial Group Inc. (1.68%). Together, the top 10 institutions control 14.3% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their TVRD positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TVRD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Slate Path Capital, LP | 704.12K | 5.28% | 0.0% |
| Vanguard Capital Management LLC | 344.38K | 2.58% | -0.1% |
| American Financial Group Inc. | 223.66K | 1.68% | 0.0% |
| UBS Group AG | 111.13K | 0.83% | +120.3% |
| Silvercrest Asset Management Group, LLC | 101.03K | 0.76% | 0.0% |
| Blackrock Inc. | 95.48K | 0.72% | -75.4% |
| Renaissance Technologies, LLC | 91.41K | 0.69% | -0.8% |
| Geode Capital Management, LLC | 90.35K | 0.68% | -50.5% |
| Morgan Stanley | 77.84K | 0.58% | +6.8% |
| Duncan Williams Asset Management, LLC | 63.24K | 0.47% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TVRD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 258.43K | 1.94% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 85.96K | 0.64% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 42.12K | 0.32% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 30.56K | 0.23% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 14.44K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.18K | 0.09% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Value Index Fund | 3.82K | 0.03% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 3.51K | 0.03% |
| Bridge Builder Trust-Bridge Builder Small/Mid Cap Value Fund | 1.98K | 0.01% |
| VALIC Co I-Small Cap Index Fund | 1.39K | 0.01% |
Frequently asked questions
Who is the largest shareholder of Tvardi Therapeutics?
Slate Path Capital, LP is the largest institutional shareholder of TVRD, owning 5.28% of shares outstanding (704.12K shares) as of its latest 13F filing.
What percentage of Tvardi Therapeutics is owned by institutions?
Institutions own about 17.3% of TVRD shares and 22.9% of the public float.
How much of Tvardi Therapeutics do insiders own?
Insiders, such as officers and directors, own about 24.36% of TVRD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.